Class [5]
Pharmaceutical Products
Pharmaceutical preparations; biopharmaceutical preparations; pharmaceutical and biopharmaceutical preparations for veterinary use; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, mood disorders, cognitive disorders, anxiety disorders, alcoholism, central nervous system movement disorders, ocular motility disorders, narcolepsy, pseudo bulbar affect, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, insomnia, bipolar disorder, seizure disorders; pharmaceutical preparations for the treatments of smoking cessation, encephalitis, cerebral palsy, Parkinson's disease, Huntington's disease, fibromyalgia and spinal cord diseases, cancer and cardiovascular disease; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, diabetic nephropathy, multiple myeloma, HIV, spasticity; pharmaceutical preparations for the relief of pain, pelvic inflammatory disease, inflammatory connective tissue diseases; none of the aforesaid preparations being for the treatment of central nervous system diseases and disorders, namely, attention deficit hyperactivity disorder and/or attention deficit disorder either alone or with related disorders.
